NF-kB ACTIVATION IN CYSTIC FIBROSIS: THE DREAM OF A20

G. Momtazi (Belfast, United Kingdom), A. Elbanna (Belfast, United Kingdom), S. Finnegan (Belfast, United Kingdom), M. Héritier (Belfast, United Kingdom), L. Lavery (Belfast, United Kingdom), K. Mccollum (Belfast, United Kingdom), J. Naranjo (Madrid, Spain), B. Schock (Belfast, United Kingdom)

Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Session: Identification of new targets and therapeutic strategies for lung disease
Session type: Thematic Poster
Number: 2371
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Momtazi (Belfast, United Kingdom), A. Elbanna (Belfast, United Kingdom), S. Finnegan (Belfast, United Kingdom), M. Héritier (Belfast, United Kingdom), L. Lavery (Belfast, United Kingdom), K. Mccollum (Belfast, United Kingdom), J. Naranjo (Madrid, Spain), B. Schock (Belfast, United Kingdom). NF-kB ACTIVATION IN CYSTIC FIBROSIS: THE DREAM OF A20. 2371

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
BLOCKAGE OF TLR4 OR NLRP3 INHIBITS IL-1ß ACTIVATION IN RESPONSE TO INTERMITTENT HYPOXIA
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020




PRO-INFLAMMATORY ACTIVITY AND OXIDATIVE STRESS ON A LINE OF CYSTIC FIBROSIS (CF) HUMAN RESPIRATORY EPITHELIUM
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018



ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019

NOVEL KLF4-FOXO1 INTERACTOME IN LUNG FIBROBLASTS:REGULATOR OF MYOFIBROBLASTS IN HYPEROXIA-INDUCED LUNG INJURY
Source: Virtual Congress 2020 – Airway development in health and disease
Year: 2020




TRANSCRIPTOMIC PROFILING REVEALS M1-HIGH TUMOUR ASSOCIATED MACROPHAGES THAT ORCHESTRATE THE ADAPTIVE ANTI-TUMOUR RESPONSE IN HUMAN LUNG CANCER
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017

E-CADHERIN GENE PROMOTER METHYLATION IN PEDIATRIC ASTHMA PATHOGENESIS AND CLINICS
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018

EVALUATION OF THE PALLIATIVE CRITERIA IN IDIOPATHIC PULMONARY FIBROSIS
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


ROLE OF TRAIL IN THE PATHOGENESIS OF BRONCHOPULMONARY DYSPLASIA (BPD)
Source: International Congress 2017 – Molecular biology of normal and abnormal lung development
Year: 2017



OSTEOPONTIN PROTECTS AGAINST LUNG INJURY CAUSED BY EXTRACELLULAR HISTONES
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

SKELETAL MUSCLE DYSFUNCTION AND BODY COMPOSITION ALTERATIONS IN NON-CYSTIC FIBROSIS BRONCHIECTASIS PATIENTS: GENDER DIFFERENCES
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020


PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021

INTERMITTENT HYPOXIA AND FRAGMENTATION OF THE DREAM INDUCE THE APPEARANCE OF HEPATIC STEATOSIS
Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Year: 2019

THE PROGRESSION OF IMMUNE DISORDERS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS ASSOCIATED WITH CHANGES IN LEUKOCYTE MEMBRANE FATTY ACID COMPOSITION
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020

PLEURO-PULMONARY COMPLICATIONS IN PATIENTS WITH CYSTIC FIBROSIS
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020

PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY.
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020


GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018


CYTOKINE RESPONSE AND CD14CD282 CELLS IN NON-SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

SERUM OSMOLARITY IS ASSOCIATED WITH SEVERITY OF OBSTRUCTIVE SLEEP APNEA SYNDROME: A NOVEL RISK FACTOR FOR CARDIOVASCULAR DISEASE
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018

“ASSESSING THE TREATMENT EFFECT FROM MULTIPLE TRIALS IN IDIOPATHIC PULMONARY FIBROSIS.” L. RICHELDI. EUR RESPIR REV 2012; 21: 147–151.
Source: Eur Respir Rev 2012 21:263
Year: 2012